|

Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery

RECRUITINGN/ASponsored by Seoul National University Hospital
Actively Recruiting
PhaseN/A
SponsorSeoul National University Hospital
Started2025-12-02
Est. completion2028-12-31
Eligibility
Age1 Month – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07304947

Summary

This prospective randomized controlled trial evaluates whether individualized cardiac index-guided intraoperative hemodynamic management reduces postoperative transient ischemic episodes in pediatric patients undergoing encephaloduroarteriosynangiosis (EDAS) for Moyamoya disease. Patients are randomized 1:1 to goal-directed fluid therapy based on baseline cardiac index versus standard arterial pressure-based management. The primary outcome is the incidence of transient ischemic episodes during hospitalization.

Eligibility

Age: 1 Month – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* Pediatric patients \<18 years undergoing EDAS for Moyamoya disease under general anesthesia

Exclusion Criteria:

* ASA physical status 4-5
* Emergency surgery
* Known cardiovascular disease
* Any condition judged inappropriate by investigators

Conditions2

Heart DiseaseMoyamoya Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.